The Incorporation of 5-Fluorouracil into RNA Affects the Ribonucleolytic Activity of the Exosome Subunit Rrp6

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Cancer Research

• Publication date

  2011-02-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/1541-7786.MCR-10-0084PMID 21289297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Core exosome-independent roles for Rrp6 in cell cycle progression.

  2009cited by this paper
• Comparative multiplexed mass spectrometric analyses of endogenously expressed yeast nuclear and cytoplasmic exosomes.

  2009cited by this paper
• The exosome associates cotranscriptionally with the nascent pre-mRNP through interactions with heterogeneous nuclear ribonucleoproteins.

  2009cited by this paper
• TRAMP Complex Enhances RNA Degradation by the Nuclear Exosome Component Rrp6*

  2009cited by this paper
• Interdependent Nucleocytoplasmic Trafficking and Interactions of Dis3 with Rrp6, the Core Exosome and Importin‐α3

  2009cited by this paper
• Structural organization of the RNA-degrading exosome.

  2008cited by this paper
• RNA-Based 5-Fluorouracil Toxicity Requires the Pseudouridylation Activity of Cbf5p

  2008influential reference
• The RNA Exosome Component hRrp6 Is a Target for 5-Fluorouracil in Human Cells

  2008influential reference
• Quality control of mRNP in the nucleus

  2008cited by this paper
• Exosome-mediated quality control: substrate recruitment and molecular activity.

  2008cited by this paper
• The exosome: a multipurpose RNA-decay machine.

  2008cited by this paper
• A single subunit, Dis3, is essentially responsible for yeast exosome core activity

  2007cited by this paper
• Expanding the nucleotide repertoire of the ribosome with post-transcriptional modifications.

  2007cited by this paper
• Methylation of endogenous human retroelements in health and disease.

  2006cited by this paper
• RNA-quality control by the exosome

  2006cited by this paper
• Chemotherapy for Colorectal Cancer

  2006cited by this paper
• Cell and molecular biology of the exosome: how to make or break an RNA.

  2006cited by this paper
• Differential distribution of exosome subunits at the nuclear lamina and in cytoplasmic foci.

  2005cited by this paper
• Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes.

  2004cited by this paper
• Effects of 5-fluorouracil on cytotoxicity and RNA metabolism in human colonic carcinoma cells

  2004cited by this paper
• 5-Fluorouracil Enhances Exosome-Dependent Accumulation of Polyadenylated rRNAs

  2004cited by this paper
• Learning Objectives

  2003cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila

  2002cited by this paper
• Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.

  2002cited by this paper
• The role of dUTPase and uracil-DNA repair in cancer chemotherapy.

  2001influential reference
• A gene expression database for the molecular pharmacology of cancer

  2000cited by this paper
• Chemotherapy for colorectal cancer.

  1994cited by this paper
• Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.

  1994cited by this paper
• Ribonucleoprotein particle assembly and modification of U2 small nuclear RNA containing 5-fluorouridine.

  1993cited by this paper
• Chemotherapy of colorectal cancer.

  1991cited by this paper
• 5-Fluorouracil substitution alters pre-mRNA splicing in vitro.

  1988cited by this paper
• Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds

  1957cited by this paper

• A non-canonical role for HIF-1α: redirecting DGCR8 to the RNA exosome for snoRNA degradation and translational modulation

  2026cites this paper
• Checkpoint-Dependent Sensitivities to Nucleoside Analogues Uncover Specific Patterns of Genomic Instability

  2025cites this paper
• Mitigation of 5-Fluorouracil-Induced Nephrotoxicity: The Protective Role of Thymoquinone and Hesperidin in vitro and in vivo

  2025cites this paper
• RNA exosome-driven RNA processing instructs the duration of the unfolded protein response

  2025cites this paper
• Smart nanocarriers for enzyme-activated prodrug therapy

  2024cites this paper
• Metabolic RNA labeling in non-engineered cells following spontaneous uptake of fluorescent nucleoside phosphate analogues

  2024cites this paper
• An RNA damage response network mediates the lethality of 5-FU in colorectal cancer

  2024cites this paper
• RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines

  2024cites this paper
• The 5‐Fluorouracil RNA Expression Viewer (5‐FUR) Facilitates Interpreting the Effects of Drug Treatment and RRP6 Deletion on the Transcriptional Landscape in Yeast

  2024cites this paper
• Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer

  2023cites this paper
• RNA decay defines the response to transcriptional perturbation in leukaemia

  2023cites this paper
• Blockade of chemo-resistance to 5-FU by a CK2-targeted combination via attenuating AhR-TLS-promoted genomic instability in human colon cancer cells.

  2023cites this paper
• Resistance to Chemotherapeutic 5-Fluorouracil Conferred by Modulation of Heterochromatic Integrity through Ino80 Function in Fission Yeast

  2023cites this paper
• An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types

  2023cites this paper
• Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective

  2023cites this paper
• Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma

  2023cites this paper
• APE1 interacts with the nuclear exosome complex protein MTR4 and is involved in cisplatin‐ and 5‐fluorouracil‐induced RNA damage response

  2022cites this paper
• Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy

  2022cites this paper
• Effect of Platelet rich plasma against the cytotoxicity induced by 5-Flurouracil in albino rats’ tongue (Histological and Immunohistochemical study)

  2022cites this paper
• [Capecitabine and vasospastic angina: a clinical case].

  2022cites this paper
• 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent

  2021cites this paper
• Regulation of the conserved 3′‐5′ exoribonuclease EXOSC10/Rrp6 during cell division, development and cancer

  2021cites this paper
• Interrogating the transcriptome with metabolically incorporated ribonucleosides.

  2021cites this paper
• EXOSC10/Rrp6 is essential for the eight-cell embryo/morula transition

  2021influential citation
• The Biological Activity Research of the Nano-Drugs Based on 5-Fluorouracil-Modified Quantum Dots

  2020cites this paper
• Protective activity of selenium against 5-fluorouracil-induced nephrotoxicity in rats

  2019cites this paper
• The anti-cancer drug 5-fluorouracil affects cell cycle regulators and potential regulatory long non-coding RNAs in yeast

  2019cites this paper
• Inhibiting eukaryotic ribosome biogenesis

  2019cites this paper
• Combined in silico and 19F NMR analysis of 5-fluorouracil metabolism in yeast at low ATP conditions

  2019cites this paper
• Ribonucleases as Drug Targets.

  2018cites this paper
• The Future of 5-Fluorouracil Treatment of Colorectal Cancer: Translating a Better Understanding into Improved Patient Care

  2018cites this paper
• Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner.

  2018cites this paper
• Post-Transcriptional Regulatory Mechanisms in the Control of Cell Identity

  2017cites this paper
• Structural and cytotoxic studies of cationic thiosemicarbazones

  2017cites this paper
• Functional consequences of RNA exosome complex alteration by conformational changes and cofactor binding

  2017cites this paper
• Phosphate crosslinked pectin based dual responsive hydrogel networks and nanocomposites: Development, swelling dynamics and drug release characteristics.

  2017cites this paper
• EXOSC10/Rrp6 is post-translationally regulated in male germ cells and controls the onset of spermatogenesis

  2017cites this paper
• Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.

  2017cites this paper
• Targeting nuclear thymidylate biosynthesis.

  2017cites this paper
• The possible protective effect of L-arginine against 5-fluorouracil-induced nephrotoxicity in male albino rats.

  2017cites this paper
• Long non-coding RNA-based mechanisms for the inhibition of cell growth and development by 5 - Fluorouracil

  2016cites this paper
• Wheat bran arabinoxylan supplementation alleviates 5-fluorouracil induced mucositis and myelosuppression in BALB/c mice

  2016cites this paper
• Exploiting nucleotide metabolism to improve cancer therapy : by targeting dUTPase, dCTPase and NUDT15

  2016cites this paper
• Genome stability versus transcript diversity.

  2016cites this paper
• Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells.

  2016cites this paper
• Effect of 5-Fluorouracil on Thymidine Phosphorylase Activity in Model Experiment

  2016cites this paper
• Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.

  2015cites this paper
• Intravenous Administration of Retroviral Replicating Vector, Toca 511, Demonstrates Therapeutic Efficacy in Orthotopic Immune-Competent Mouse Glioma Model

  2015cites this paper
• ALPPL2 Aptamer-Mediated Targeted Delivery of 5-Fluoro-2′-Deoxyuridine to Pancreatic Cancer

  2015cites this paper
• Effect of 5-Fluorouracil on translational regulation in colorectal cancer cells

  2015cites this paper
• Ein intrinsisch 5‐Fluor‐2′‐desoxyuridin beinhaltendes Aptamer für die gezielte Chemotherapie

  2014cites this paper
• An aptamer intrinsically comprising 5-fluoro-2'-deoxyuridine for targeted chemotherapy.

  2014cites this paper
• Saccharomyces cerevisiae: A Platform for Structure-activity Relationship Analysis and High-throughput Candidate Prioritization

  2013cites this paper
• The effects of 5-fluorouracil on the proteome of colon cancer cells.

  2013cites this paper
• Characterization of the RNA binding and RNA degrading subunits of the eukaryotic exosome

  2013cites this paper
• The Molecular Mechanisms of 5-Fluorouracil-Induced Apoptosis in Human Colorectal Cancer Cells and the Use of 5-FU as a Sensitising Agent to TRAIL

  2012cites this paper
• Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.

  2012cites this paper
• Influence of MTHFR 1298A→C polymorphism on response to transarterial chemoembolization in primary hepatocellular carcinoma: A pilot study

  2011cites this paper
• Checkpoint Signaling, Base Excision Repair, and PARP Promote Survival of Colon Cancer Cells Treated with 5-Fluorodeoxyuridine but Not 5-Fluorouracil

  2011cites this paper
• UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation

  2011cites this paper